Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313177790> ?p ?o ?g. }
- W4313177790 endingPage "197" @default.
- W4313177790 startingPage "191" @default.
- W4313177790 abstract "Background and aim An optimal sequential anti-hepatocellular carcinoma (HCC) agent that can be used after failed lenvatinib treatment has not been established. Here, we compared the outcomes of sorafenib and nivolumab as second-line agents after failed lenvatinib treatment in patients with advanced HCC. Methods Patients with advanced HCC who had received sorafenib or nivolumab as second-line agents after failed lenvatinib treatment were recruited from two Korean tertiary institutions between November 2018 and June 2020. Results The median age of the 60 participants (52 treated with sorafenib and eight treated with nivolumab) at baseline was 56.8 years. The demographic, laboratory and tumor variables, as well as lenvatinib treatment duration, were similar between the two groups. The median durations of sorafenib and nivolumab treatment were 1.2 and 2.6 months, respectively ( P = 0.164). Twenty-four (40.0%) patients died during the follow-up period (median, 15.8 months). The median overall survival (OS) of the study population was 5.8 months. The median OS of patients treated with sorafenib was significantly longer than the median OS of patients treated with nivolumab (8.7 vs. 3.0 months; P = 0.046). Sorafenib treatment (vs. nivolumab) was independently associated with a lower risk of mortality (hazard ratio = 0.194; 95% confidence interval, 0.053–0.708; P = 0.013). Worse Eastern Cooperative Oncology Group performance status, larger maximal tumor size, lymph node metastases and higher total bilirubin levels were independently associated with increased mortality risk (all P < 0.05). Conclusions Lenvatinib-sorafenib sequential treatment resulted in significantly better survival did than lenvatinib-nivolumab sequential treatment in patients with advanced HCC. Larger studies are needed to validate our results." @default.
- W4313177790 created "2023-01-06" @default.
- W4313177790 creator A5026763303 @default.
- W4313177790 creator A5034859542 @default.
- W4313177790 creator A5040109906 @default.
- W4313177790 creator A5046178076 @default.
- W4313177790 creator A5046452850 @default.
- W4313177790 creator A5049575773 @default.
- W4313177790 creator A5054417741 @default.
- W4313177790 creator A5067263547 @default.
- W4313177790 creator A5081813546 @default.
- W4313177790 date "2022-11-01" @default.
- W4313177790 modified "2023-10-14" @default.
- W4313177790 title "Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma" @default.
- W4313177790 cites W1971837077 @default.
- W4313177790 cites W2079586464 @default.
- W4313177790 cites W2100945326 @default.
- W4313177790 cites W2107564997 @default.
- W4313177790 cites W2194546364 @default.
- W4313177790 cites W2277004004 @default.
- W4313177790 cites W2529646902 @default.
- W4313177790 cites W2560499218 @default.
- W4313177790 cites W2606367731 @default.
- W4313177790 cites W2787358630 @default.
- W4313177790 cites W2904776407 @default.
- W4313177790 cites W2914296513 @default.
- W4313177790 cites W2948172856 @default.
- W4313177790 cites W2985556259 @default.
- W4313177790 cites W3000185623 @default.
- W4313177790 cites W3000401463 @default.
- W4313177790 cites W3028482830 @default.
- W4313177790 cites W3029320124 @default.
- W4313177790 cites W3038373553 @default.
- W4313177790 cites W3045557449 @default.
- W4313177790 cites W3049757680 @default.
- W4313177790 cites W3080424252 @default.
- W4313177790 cites W3087612465 @default.
- W4313177790 cites W3102437787 @default.
- W4313177790 cites W3122656440 @default.
- W4313177790 cites W3204684414 @default.
- W4313177790 cites W4230036506 @default.
- W4313177790 cites W4232620598 @default.
- W4313177790 doi "https://doi.org/10.1097/meg.0000000000002466" @default.
- W4313177790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36574310" @default.
- W4313177790 hasPublicationYear "2022" @default.
- W4313177790 type Work @default.
- W4313177790 citedByCount "2" @default.
- W4313177790 countsByYear W43131777902023 @default.
- W4313177790 crossrefType "journal-article" @default.
- W4313177790 hasAuthorship W4313177790A5026763303 @default.
- W4313177790 hasAuthorship W4313177790A5034859542 @default.
- W4313177790 hasAuthorship W4313177790A5040109906 @default.
- W4313177790 hasAuthorship W4313177790A5046178076 @default.
- W4313177790 hasAuthorship W4313177790A5046452850 @default.
- W4313177790 hasAuthorship W4313177790A5049575773 @default.
- W4313177790 hasAuthorship W4313177790A5054417741 @default.
- W4313177790 hasAuthorship W4313177790A5067263547 @default.
- W4313177790 hasAuthorship W4313177790A5081813546 @default.
- W4313177790 hasConcept C121608353 @default.
- W4313177790 hasConcept C126322002 @default.
- W4313177790 hasConcept C143998085 @default.
- W4313177790 hasConcept C207103383 @default.
- W4313177790 hasConcept C2776264508 @default.
- W4313177790 hasConcept C2777701055 @default.
- W4313177790 hasConcept C2778019345 @default.
- W4313177790 hasConcept C2778695046 @default.
- W4313177790 hasConcept C2780030458 @default.
- W4313177790 hasConcept C44249647 @default.
- W4313177790 hasConcept C71924100 @default.
- W4313177790 hasConcept C90924648 @default.
- W4313177790 hasConceptScore W4313177790C121608353 @default.
- W4313177790 hasConceptScore W4313177790C126322002 @default.
- W4313177790 hasConceptScore W4313177790C143998085 @default.
- W4313177790 hasConceptScore W4313177790C207103383 @default.
- W4313177790 hasConceptScore W4313177790C2776264508 @default.
- W4313177790 hasConceptScore W4313177790C2777701055 @default.
- W4313177790 hasConceptScore W4313177790C2778019345 @default.
- W4313177790 hasConceptScore W4313177790C2778695046 @default.
- W4313177790 hasConceptScore W4313177790C2780030458 @default.
- W4313177790 hasConceptScore W4313177790C44249647 @default.
- W4313177790 hasConceptScore W4313177790C71924100 @default.
- W4313177790 hasConceptScore W4313177790C90924648 @default.
- W4313177790 hasIssue "2" @default.
- W4313177790 hasLocation W43131777901 @default.
- W4313177790 hasLocation W43131777902 @default.
- W4313177790 hasOpenAccess W4313177790 @default.
- W4313177790 hasPrimaryLocation W43131777901 @default.
- W4313177790 hasRelatedWork W2791311396 @default.
- W4313177790 hasRelatedWork W2806906789 @default.
- W4313177790 hasRelatedWork W2979385728 @default.
- W4313177790 hasRelatedWork W3016320614 @default.
- W4313177790 hasRelatedWork W3026696662 @default.
- W4313177790 hasRelatedWork W3101944901 @default.
- W4313177790 hasRelatedWork W3154711057 @default.
- W4313177790 hasRelatedWork W3164491560 @default.
- W4313177790 hasRelatedWork W4246003612 @default.
- W4313177790 hasRelatedWork W4253087965 @default.
- W4313177790 hasVolume "35" @default.